Company: HCWB
Filing Date: 2025-04-14
Form Type: 8-K
Source: 0000950170-25-053745
Chunk: 0

Company: HCW Biologics Inc.
Filing Date: 2025-04-14
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive Agreement.

On February 20, 2025, HCW Biologics Inc. (the “ Company”), entered into an Equity Purchase Agreement (the “ Equity Purchase Agreement”) and a registration rights agreement (the “ Registration Rights Agreement”) with Square Gate Capital Master Fund, LLC - Series 4 (the “ Investor”), as the Company previously reported on Form 8-K filed on February 21, 2025. Pursuant to the terms of the Registration Rights Agreement with the Investor, the Company agreed to submit an initial registration statement on Form S-1 (as amended, the “ Registration Statement”) to the U. S. Securities and Exchange Commission (the “ SEC”) by April 6, 2025.

The information set forth under Item 8.1 below is incorporated by reference into this Item 1.01.